In the BioHarmony Drug Report Database

"Preview" Icon

Medroxyprogesterone

Depo-provera, Depo-subq Provera, Provera (medroxyprogesterone acetate) is a small molecule pharmaceutical. Medroxyprogesterone acetate was first approved as Depo-provera on 1982-01-01. It is used to treat amenorrhea, breast neoplasms, endometrial hyperplasia, endometrial neoplasms, and hypoventilation amongst others in the USA. The pharmaceutical is active against progesterone receptor.

 

Trade Name

 

Depo-provera, Depo-subq Provera, Provera
 

Common Name

 

medroxyprogesterone acetate
 

ChEMBL ID

 

CHEMBL717
 

Indication

 

amenorrhea, breast neoplasms, endometrial hyperplasia, endometrial neoplasms, hypoventilation, renal cell carcinoma, uterine hemorrhage
 

Drug Class

 

Progestins; steroids (androgens, anabolics)

Image (chem structure or protein)

Medroxyprogesterone structure rendering